Revamedical
1 known investors
REVA Medical develops and sells bioresorbable polymer-based implantable medical devices for vascular applications, including the MOTIV bioresorbable scaffold for below-the-knee peripheral artery disease, TyroSphere embolic microspheres for hypervascular tumors, and the Fantom Encore coronary bioresorbable scaffold. Its products use a proprietary polymer called Tyrocore and serve interventional vascular medicine.
Investors Β· 1
Non-dilutive funding Β· 1 SBIR/STTR award
Federal grants β no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2004 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts β non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Revamedical do?
- REVA Medical develops and sells bioresorbable polymer-based implantable medical devices for vascular applications, including the MOTIV bioresorbable scaffold for below-the-knee peripheral artery disease, TyroSphere embolic microspheres for hypervascular tumors, and the Fantom Encore coronary bioresorbable scaffold. Its products use a proprietary polymer called Tyrocore and serve interventional vascular medicine.
- Who are Revamedical's investors?
- Revamedical's investors include Corewell Health Ventures.